Raras
Buscar doenças, sintomas, genes...
Sarcoma pleomórfico indiferenciado
ORPHA:2023CID-10 · C49.9DOENÇA RARA

Sarcoma indiferenciado de partes moles caracterizado pela presença de infiltrado celular maligno pleomórfico. Também é conhecido como histiocitoma fibroso maligno.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Sarcoma indiferenciado de partes moles caracterizado pela presença de infiltrado celular maligno pleomórfico. Também é conhecido como histiocitoma fibroso maligno.

Pesquisas ativas
21 ensaios
95 total registrados no ClinicalTrials.gov
Publicações científicas
1.157 artigos
Último publicado: 2026 Mar

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-9 / 100 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Europe
Início
Adolescent
+ adult, childhood, elderly
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: C49.9
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🦴
Ossos e articulações
2 sintomas
📏
Crescimento
2 sintomas
💪
Músculos
1 sintomas

+ 4 sintomas em outras categorias

Características mais comuns

90%prev.
Anormalidade do membro inferior
Muito frequente (99-80%)
90%prev.
Sarcoma de tecido mole
Muito frequente (99-80%)
90%prev.
Morfologia anormal do peritônio
Muito frequente (99-80%)
55%prev.
Febre
Frequente (79-30%)
55%prev.
Morfologia anormal da musculatura
Frequente (79-30%)
17%prev.
Fadiga
Ocasional (29-5%)
9sintomas
Muito frequente (3)
Frequente (2)
Ocasional (4)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 9 características clínicas mais associadas, ordenadas por frequência.

Anormalidade do membro inferiorAbnormality of the lower limb
Muito frequente (99-80%)90%
Sarcoma de tecido moleSoft tissue sarcoma
Muito frequente (99-80%)90%
Morfologia anormal do peritônioAbnormality of the peritoneum
Muito frequente (99-80%)90%
FebreFever
Frequente (79-30%)55%
Morfologia anormal da musculaturaAbnormality of the musculature
Frequente (79-30%)55%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico1.157PubMed
Últimos 10 anos200publicações
Pico2025125 papers
Linha do tempo
2026Hoje · 2026🧪 1995Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

🧬

Nenhum gene associado encontrado

Os dados genéticos desta condição ainda estão sendo catalogados.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
3Fase 32
2Fase 211
1Fase 14
·Pré-clínico3
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 20 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Sarcoma pleomórfico indiferenciado

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

11 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

95 ensaios clínicos encontrados, 21 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
1.008 papers (10 anos)

Mostrando amostra de 200 publicações de um total de 1.008

#1

Severe mitral stenosis due to primary cardiac intimal sarcoma: case report.

European heart journal. Case reports2026 Mar

Primary cardiac tumours are exceedingly rare with intimal sarcomas being the rarest subtype of malignant cardiac sarcomas. These tumours are characterized by late presentation, haemodynamic compromise, and poor prognosis due to their rapid progression and metastatic potential. Multimodal management is essential given the lack of standardized guidelines. A 64-year-old female presented with heart failure and atrial fibrillation. An echocardiogram revealed a 48 mm obstructive intra-cardiac mass in the left atrium causing severe functional mitral stenosis. Given recurrent episodes of flash pulmonary oedema secondary to mitral stenosis, a multi-disciplinary decision was made to proceed with high-risk surgical debulking. The patient underwent resection with pathology showing an undifferentiated pleomorphic sarcoma with evidence of MDM2 amplification, in keeping with an intimal sarcoma. She was discharged home in stable condition but had progression of disease despite treatment with doxorubicin. She died 6 months after from a haemorrhagic stroke. Intimal sarcomas carry a dismal prognosis due to late-stage detection and challenges with complete resection. While anthracycline-based chemotherapy and surgical resection may modestly extend survival, recurrence and metastases remain common. This case underscores the aggressive nature of cardiac intimal sarcoma and the vital role of early diagnosis and coordinated, multi-disciplinary care. Additionally, the psychosocial toll of such a devastating illness necessitates early integration of supportive services to address patient and family needs during a rapidly evolving clinical course.

#2

A Phase 1 Study of Neoadjuvant Cabozantinib in Combination With Radiation Therapy for Sarcomas of the Extremities.

American journal of clinical oncology2026 Feb 23

Cabozantinib demonstrates activity in multiple soft tissue sarcoma (STS) subtypes, but use with concurrent radiation therapy (RT) has been limited by concern for risk of fistula or perforation. This phase 1 trial evaluated the safety of concurrent cabozantinib and RT as neoadjuvant therapy in patients with extremity STS. Adults with newly diagnosed localized extremity STS planned for neoadjuvant RT and surgical resection were eligible. Participants received radiation with 5000 to 5040 cGy with conventional fractionation and cabozantinib 40 mg or 60 mg daily. Patients were observed for dose-limiting toxicity (DLT) up to 28 days after completion of concurrent cabozantinib/RT. The primary objective was to identify a recommended phase 2 dose (RP2D) of cabozantinib for combination with RT, and secondary objectives included estimating rates of treatment-related adverse event (TRAE), margin positivity, and objective response. Six patients were enrolled with histologic subtypes of undifferentiated pleomorphic sarcoma, myxofibrosarcoma, leiomyosarcoma, and myxoid liposarcoma. No DLT due to the combination of cabozantinib and radiation was observed, but 3/6 (50%) patients required dose-reduction due to TRAE of cabozantinib alone. No grade ≥3 toxicities were attributed to RT. The RP2D was cabozantinib 60 mg. Six (100%) patients demonstrated stable disease at 12 weeks, and 5 (83%) underwent R0 resection. Two (33%) patients experienced metastatic relapse, and 1 (17%) died without relapse; 3 (50%) patients survived without relapse by last contact. No local recurrences occurred. In this phase 1 trial, concurrent cabozantinib/RT was feasible and demonstrated an acceptable safety profile for patients with extremity STS.

#3

Single-Cell RNA Sequencing Reveals the Cellular and Molecular Differences Between Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma.

Medical sciences (Basel, Switzerland)2026 Feb 10

Objective: Myxofibrosarcoma (MXF) and undifferentiated pleomorphic sarcoma (UPS) are common and aggressive subtypes of cancer differing by clinical characteristics and prognosis; however, their differential diagnosis is difficult. Elucidation of cellular and transcriptomic discrepancies between these diseases that could improve their identification was the aim of our study. Methods: We applied single-cell RNA sequencing to compare MXF and UPS by tumor cell clusters and cell-cell ligand-receptor interactions, using five tumor samples of both subtypes. Results: We identify nine major cell types in all tumors analyzed. Any significant differences in their proportions between MXF and UPS were not found. Further reclusterization of lymphoid cells showed that cytotoxic CD8+ T cell proportion was higher in the MXF samples. In UPS cancer cells, the pathways maintaining extracellular matrix components (including collagens, proteoglycans, and other proteins) were highly active, while MXF cells were characterized by high activity of growth factors and angiogenesis pathways. The ligand-receptor interactions between cancer cells and the microenvironment differed significantly between MXF and UPS. In UPS, CD80 of dendritic cells and macrophages prominently interacted with T cell co-inhibitory CTLA-4 receptors, whereas the activating CD80-CD28 interaction was predominant in MXF. Moreover, in UPS, CD44 and integrins of cytotoxic CD8+ T cells prominently interacted with COL1A1/2, while in MXF CD44, interaction with FN1, COL6A1, and LAMC1 prevailed. Conclusions: Differences were identified between UPS and MFS in the composition of lymphoid cell populations and in the intercellular interactions. This proposes deeper understanding of the biological differences between these sarcoma subtypes and may be important for the development of new therapeutic approaches, although further validation of the findings is required.

#4

Immunoreactivity for CD34, Desmin, Keratins, KIT, Alpha-Smooth Muscle Actin, S100, and Vimentin in Malignant Mesenchymal Neoplasms in Guinea Pigs: A Series of 62 Cases From a Single Institution.

Veterinary medicine and science2026 Mar

There has been a lack of research regarding diagnostic immunohistochemistry in soft tissue pathology in rodents. We aimed to analyse the immunohistochemical expression of CD34, keratin AE1/AE3, keratin 8/18, desmin, KIT, SMA, S100, and vimentin in various malignant mesenchymal tumours in guinea pigs. A total of 62 tumours included 10 fibrosarcomas, 8 myxosarcomas, 8 undifferentiated pleomorphic sarcomas, 6 undifferentiated round cell sarcomas, 6 dedifferentiated liposarcomas (involving deep soft tissue, skin or subcutis), 12 uterine leiomyosarcomas, 4 hemangiosarcomas (involving skin and spleen), and 8 gastrointestinal stromal tumours (GIST). Desmin and SMA positivity was present in tumours of various lineages, including hemangiosarcoma. CD34 positivity was restricted to hemangiosarcomas, GISTs and one case of undifferentiated pleomorphic sarcoma, whereas KIT positivity was detected only in GISTs. Lesser amounts of keratins positivity were observed in fibrosarcoma, myxosarcoma, undifferentiated pleomorphic sarcoma, and dedifferentiated liposarcoma. S100 positivity was identified in myxosarcoma, undifferentiated pleomorphic sarcoma, and dediffentiated liposarcoma and vimentin positivity was detected in all tumour types. The strong and diffuse staining pattern of desmin and SMA can be very helpful in distinguishing leiomyosarcoma from its spindle cell mimics. A novel finding is that SMA positivity was identified in malignant endothelium. Immunolabelling for CD34 and KIT provides reliable markers for vascular neoplasms and GISTs. Vimentin does not allow to distinguish between different mesenchymal malignancies in guinea pigs. Occasional positivity for keratins and S100 points to potential pitfalls and emphasised the need for a panel of immunohistochemical stains in the investigation of mesenchymal tumours.

#5

A Japanese Multicenter Database Study of Retroperitoneal Sarcoma: Outcomes of Patients Receiving Eribulin Therapy.

Asia-Pacific journal of clinical oncology2026 Jan 22

Clinical evidence on disease characteristics and outcomes of retroperitoneal sarcoma (RPS) remains limited. Although eribulin was approved for soft tissue sarcomas in Japan in 2016, real-world data on its use for advanced RPS are scarce. We investigated treatment patterns and survival outcomes of patients with RPS, with a particular focus on those receiving eribulin. The database included 118 patients pathologically diagnosed with RPS between January 2000 and August 2025. Clinicopathologic data, including inflammation/nutrition markers and survival outcomes, were analyzed. Among them, 102 (86%) underwent surgical resection of the primary tumor, with a median recurrence-free survival of 20 months and a median overall survival of 9.2 years. Well-differentiated liposarcoma, dedifferentiated liposarcoma, leiomyosarcoma, and undifferentiated pleomorphic sarcoma were the most frequent histologic subtypes. Non-well-differentiated liposarcoma histology, Stage IIIA-IIIB, lower C-reactive protein-albumin-lymphocyte index, and higher modified neutrophil-platelet score were associated with poor postoperative prognosis. Of 44 patients with unresectable RPS who received systemic therapy, 23 (52%) were treated with eribulin. In this group, complete response, partial response, and stable disease rates were 4.3%, 26%, and 35%, respectively. The most common adverse events were decreased neutrophil count (40%), peripheral neuropathy (30%), and dysgeusia (20%). Multivariate analysis showed that non-use of eribulin and undifferentiated pleomorphic sarcoma were independently associated with worse survival in unresectable disease. We separately described outcomes and treatment patterns of patients with resectable and unresectable RPS. Our findings suggest that eribulin should be considered a treatment option for unresectable RPS in clinical practice.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC445 artigos no totalmostrando 200

2026

Wide resection and reconstruction using the sandwich technique for primary undifferentiated pleomorphic sarcoma of the sternum: a case report.

General thoracic and cardiovascular surgery cases
2026

Treatment paradigms in undifferentiated pleomorphic sarcoma of bone: lessons learned from osteosarcoma and questions that remain commentary on: Bielack SS et al. J Cancer Res Clin Oncol (2026).

Journal of cancer research and clinical oncology
2026

Distinct immunologic patterns of response and resistance to anti-PD-1/PD-L1-based immunotherapy in patients with soft tissue sarcoma.

Frontiers in immunology
2026

Proteomic landscape analysis of undifferentiated pleomorphic sarcoma.

Genome medicine
2026

Severe mitral stenosis due to primary cardiac intimal sarcoma: case report.

European heart journal. Case reports
2026

Case Report: A rare case of primary undifferentiated pleomorphic sarcoma of the renal pelvis with high PD-L1 expression and a misleading positive urine FISH.

Frontiers in immunology
2026

Revisiting the Immune Frontier in Soft Tissue Sarcomas.

Current oncology reports
2026

Safety and Efficacy of Epirubicin, Ifosfamide, and Nivolumab as First-line treatment for patients with Undifferentiated Pleomorphic Sarcoma.

Clinical cancer research : an official journal of the American Association for Cancer Research
2026

Radiation-Associated Sarcoma in a Resource-Constrained Setting: A Decade of Real-World Outcomes From a Tertiary Care Sarcoma Center in India.

JCO global oncology
2026

Undifferentiated testicular pleomorphic sarcoma: A case report.

World journal of clinical cases
2026

Red Bumps, Red Flags: A Case Series of Four Neoplasms Masquerading as Inflamed Cutaneous Cysts.

Cureus
2026

Performance of deep learning-based segmentation of soft tissue sarcoma by MRI sequence, tumor type and location.

Skeletal radiology
2026

A Phase 1 Study of Neoadjuvant Cabozantinib in Combination With Radiation Therapy for Sarcomas of the Extremities.

American journal of clinical oncology
2026

Case Report: Complete response to the concurrent neoadjuvant radiation therapy and pembrolizumab in a locally recurrent, chemotherapy-refractory undifferentiated pleomorphic sarcoma of bone.

Frontiers in oncology
2026

Clinical Characteristics of Complex Karyotype Soft Tissue Sarcomas: A Single-Institution Cohort Study.

Medicina (Kaunas, Lithuania)
2026

Molecular epidemiology of the expression of urokinase plasminogen activator receptor-associated protein (uPARAP) in mesenchymal malignancies.

Translational oncology
2026

Undifferentiated High-Grade Pleomorphic Sarcoma of the Posterior Mandible: A Report of a Rare Case.

Cureus
2026

Commentary: Undifferentiated pleomorphic sarcoma of the adrenal gland: a case report and literature review.

Frontiers in oncology
2026

Single-Cell RNA Sequencing Reveals the Cellular and Molecular Differences Between Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma.

Medical sciences (Basel, Switzerland)
2026

Malignant transformation of fibrous dysplasia in long bones: a clinicopathological and molecular study of 19 cases.

Journal of clinical pathology
2026

PATIENTS WITH SOFT TISSUE SARCOMA AFTER TREATMENT BY NON ORTHOPEDIC ONCOLOGIC SURGEONS: EPIDEMIOLOGICAL PROFILE, STAGING, AND THERAPEUTIC CHALLENGES.

Acta ortopedica brasileira
2026

Pathological Study of Rare Malignant Cardiac Tumors: A Case Series of Five Patients.

Case reports in pathology
2026

Transcriptomic subgroups in soft tissue tumors correlate with morphologic subtype, genomic features, and outcome.

Clinical cancer research : an official journal of the American Association for Cancer Research
2026

Adenosine A2B Receptor Promotes Tumor Progression and Metastases in Undifferentiated Pleomorphic Sarcoma.

Clinical cancer research : an official journal of the American Association for Cancer Research
2026

Immunoreactivity for CD34, Desmin, Keratins, KIT, Alpha-Smooth Muscle Actin, S100, and Vimentin in Malignant Mesenchymal Neoplasms in Guinea Pigs: A Series of 62 Cases From a Single Institution.

Veterinary medicine and science
2026

Intraoperative MRI for giant cell tumor of bone after denosumab and other selected tumors: A pilot study.

Acta radiologica open
2026

A Japanese Multicenter Database Study of Retroperitoneal Sarcoma: Outcomes of Patients Receiving Eribulin Therapy.

Asia-Pacific journal of clinical oncology
2026

Retroperitoneal undifferentiated pleomorphic sarcoma with aortic and inferior vena cava involvement presenting as right common iliac artery rupture.

Journal of vascular surgery cases and innovative techniques
2026

Real-World Implementation of Next-Generation Sequencing in Sarcoma: Molecular Insights and Therapeutic Outcomes.

Medical sciences (Basel, Switzerland)
2026

Undifferentiated pleomorphic sarcoma of bone (UPSB) treated in the German-speaking countries. A report of 132 unselected patients from the Cooperative Osteosarcoma Study Group (COSS).

Journal of cancer research and clinical oncology
2026

A Rare Case of Recurrent Sarcoma Presenting as an Anterior Mediastinal Mass: Case Report.

Case reports in oncology
2025

A retrospective study of post-radiation sarcoma from three institutions in Japan with a review of the literature.

Nagoya journal of medical science
2026

Pathologic Assessment of Retroperitoneal Sarcomas: A Position Paper By the Transatlantic Australasian Retroperitoneal Sarcoma Working Group.

The American journal of surgical pathology
2026

Targeted RNA sequencing enhances the integrated diagnosis of bone and soft tissue tumors.

Human pathology
2026

Combined Use of a Pedicled Medial Sural Artery Perforator Flap and a V-Y Advancement Flap Based on an Anterior Tibial Artery Perforator for Pretibial Defect Reconstruction: A Case Report.

Microsurgery
2026

Management of intracranial undifferentiated pleomorphic sarcoma: a systematic review.

Neurosurgical review
2026

Dual role of IFNγ in reprogramming the undifferentiated pleomorphic sarcoma cell line JBT19 towards cytotoxic chemotherapy and antitumor immunity.

Oncology letters
2025

Primary Cardiac Sarcomas: Clinical Characteristics, Management, and Outcomes at a Spanish National Reference Center.

Cancers
2025

Prominent repair-like changes that mimic atypical squamous cells after radiation treatment in the lung: A report of two cases.

CytoJournal
2025

Applying Radiomics to Predict Outcomes in Patients with High-Grade Retroperitoneal Sarcoma Treated with Preoperative Radiotherapy.

Journal of imaging
2026

Osteogenesis Imperfecta Type V With Undifferentiated Pleomorphic Sarcoma: A Rare Occurrence.

Pediatric blood &amp; cancer
2025

Clinicopathological and genomic profiling in undifferentiated pleomorphic sarcoma: Small series, clear message.

Journal of applied genetics
2025

The prognostic value of systemic inflammatory response index (SIRI) and CD8 + tumor-infiltrating lymphocytes for patients with localized undifferentiated pleomorphic sarcoma of soft tissue.

BMC cancer
2026

Delayed Treatment Associated With Worse Survival in High-grade Undifferentiated Pleomorphic Sarcoma.

The Journal of surgical research
2025

Distal Upper Extremity Sarcoma Epidemiology: A Single-Institution Review.

Hand (New York, N.Y.)
2025

Pericardial Sarcoma of Uncertain Origin in a Young Cat: A Case Report Highlighting Diagnostic Challenges and Thoracic Drainage in Palliative Management.

Animals : an open access journal from MDPI
2025

The Immune Landscape of Canine Soft Tissue Sarcomas as a Model for Human Soft Tissue Sarcomas.

Cancers
2025

Single-Cell Sequencing Reveals Novel Tumor Populations and Their Interplay with the Immune Microenvironment in a Pleomorphic Rhabdomyosarcoma.

International journal of molecular sciences
2025

ATRX loss in sarcomas is associated with dysregulated gene and transposable element expression, loss of DNA methylation, and worse survival.

medRxiv : the preprint server for health sciences
2025

High-throughput screening identifies the activity of histone deacetylase inhibitors in patient-derived models of soft tissue sarcoma.

Cancer biology &amp; therapy
2025

Genetic Heterogeneity of Undifferentiated Pleomorphic Sarcoma: Is There Potential for Targeted Therapy?

Cancers
2026

Profiling the genomic landscape and evolutionary history of polyploid giant cancer cells in undifferentiated pleomorphic sarcomas.

Cancer letters
2025

Pembrolizumab combined with surgical treatment for spontaneously ruptured undifferentiated pleomorphic sarcoma of the liver: a case report and literature review.

Frontiers in immunology
2025

Periacetabular Resection for Bone Tumors: Is There Still a Role for Massive Allograft-prosthesis Composite Reconstructions?

Clinical orthopaedics and related research
2025

Distinct Sarcoma Microenvironments Predict Benefit from Addition of Pembrolizumab to Preoperative Radiotherapy and Surgery in SU2C-SARC032.

medRxiv : the preprint server for health sciences
2025

A signal-seeking phase 2 study of tremelimumab in advanced cancers with high tumour mutational burden.

NPJ precision oncology
2026

ASO Visual Abstract: Advancing Prognostics in Oncology: Developing a Machine Learning Model for Predicting 2-Year and 5-Year Survival Rates in Patients with Undifferentiated Pleomorphic Sarcoma.

Annals of surgical oncology
2025

[Effectiveness evaluation of three-dimensional printed customized hemi-pelvic prosthesis for pelvic reconstruction after resection of massive pelvic tumor].

Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery
2025

Intracranial undifferentiated pleomorphic sarcoma of right frontal lobe: a case report.

Discover oncology
2025

Oncolytic measles virotherapy encoding the neutrophil-activating protein is effective in synovial sarcoma.

Molecular therapy. Oncology
2025

Ectopic Adrenocorticotropic Hormone Syndrome Secondary to Undifferentiated Pleomorphic Sarcoma of the Thigh: A Rare Paraneoplastic Manifestation.

Cureus
2026

Deep-Learning Tool ScVital Enables Species-Agnostic Integration of Cancer Cell States.

Cancer research
2025

Imaging Findings of Atypical Spindle Cell/Pleomorphic Lipomatous Tumors: A Case Series and Systematic Review.

Cureus
2025

A Rare Case of High-Grade Undifferentiated Pleomorphic Sarcoma of the Terminal Ileum in a 40-Year-Old Man: Successful Outcome and Prolonged Survival After Surgical Resection and Adjuvant Chemotherapy.

Cureus
2025

High-Grade Undifferentiated Pleomorphic Sarcoma of the Tongue: A Case Report.

Cureus
2025

Impact of Proximity to an Academic Health Center on Adherence to the National Comprehensive Cancer Network (NCCN) Guidelines in Patients With Soft Tissue Sarcomas.

Cureus
2025

Incidence and prognostic impact of regional lymph node metastasis at the time of diagnosis in soft-tissue sarcoma : a population-based cohort study.

The bone &amp; joint journal
2025

Orthopedic Surgical Management of Soft Tissue Sarcomas in a Referral Center: 5-Year Oncological Outcomes.

Orthopaedics &amp; traumatology, surgery &amp; research : OTSR
2025

A rare case of cellular angiofibroma with sarcomatous transformation occurred in the popliteal fossa.

Discover oncology
2025

Salvage resection after immunotherapy for giant undifferentiated pleomorphic sarcoma of the chest wall.

Journal of surgical case reports
2025

Is the Thickness of the Margin Associated with Local Recurrence and Survival in Patients with Undifferentiated Pleomorphic Sarcoma?

Medicina (Kaunas, Lithuania)
2025

Succinate Dehydrogenase B (SDHB) Overexpression with Enzymatic Dysfunction Defines a Distinct Subtype of Undifferentiated Pleomorphic Sarcoma.

Cancer research communications
2025

Atypical Fibroxanthoma: Trends and Insights From a Single Tertiary Care Institution Over a Ten-Year Span.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
2026

Aortic Pleomorphic Sarcoma Presenting With Claudication: A Rare Diagnostic Challenge.

Vascular and endovascular surgery
2025

The prognostic potential of circulating biomarkers for sarcoma patients with pleural dissemination.

Pathology oncology research : POR
2025

The value of morphology: osteoclast-like cells in soft tissue tumours.

Pathology oncology research : POR
2025

Imaging findings for differentiating and predicting prognosis in undifferentiated pleomorphic sarcoma and myxofibrosarcoma.

European journal of radiology
2026

ASO Author Reflections: Advancing Prognostics in Oncology: Developing a Machine Learning Model for Predicting 2-Year and 5-Year Survival Rates in Patients with Undifferentiated Pleomorphic Sarcoma.

Annals of surgical oncology
2025

The clinical outcomes of joint-preserving endoprosthesis reconstruction for primary sarcomas about the knee.

Journal of orthopaedic surgery and research
2025

Deconstructing the prevalence of undifferentiated pleomorphic sarcoma across socio-demographic groups: a potential launchpad for future research.

Dermatology online journal
2025

Characteristics and Outcomes of Soft Tissue Sarcoma in Saudi Arabia: A 10-Year Experience.

Cancer management and research
2025

The levels of circulating tumor DNA and inflammatory proteins depict the clinical response in a patient with metastatic undifferentiated pleomorphic sarcoma, a case report.

Acta oncologica (Stockholm, Sweden)
2025

Advancing Prognostics in Oncology: Developing a Machine Learning Model for Predicting 2-Year and 5-Year Survival Rates in Patients with Undifferentiated Pleomorphic Sarcoma.

Annals of surgical oncology
2025

Epidemiology and Outcomes of Retroperitoneal Sarcoma: An Analysis of the Population-Based Cancer Registry in Japan 2016-2019.

Journal of surgical oncology
2025

Immunotherapy in the Treatment of Undifferentiated Pleomorphic Sarcoma and Myxofibrosarcoma.

Current treatment options in oncology
2025

Primary Cardiac Sarcoma: A Rare Case With Superior Vena Cava Syndrome.

In vivo (Athens, Greece)
2025

Priming the tumor microenvironment with pembrolizumab and radiotherapy for durable cures in high-risk localized undifferentiated pleomorphic sarcoma and pleomorphic/dedifferentiated liposarcoma.

Journal for immunotherapy of cancer
2025

A real-world study on the expression and clinical application of IMP3 immunohistochemistry in bone tumors.

Human pathology
2025

Case Report: A rare case of hepatic undifferentiated pleomorphic sarcoma: diagnostic dilemmas and multidisciplinary management strategies.

Frontiers in oncology
2025

Case Report: Three-year follow-up of TACE for recurrent undifferentiated pleomorphic sarcoma: sustained local control and no systemic progression.

Frontiers in oncology
2025

GTSE1-expressed osteoblastic cells facilitate formation of pro-metastatic tumor microenvironment in osteosarcoma.

Genes &amp; diseases
2025

Primary undifferentiated pleomorphic sarcoma of biceps femoris.

Indian journal of cancer
2025

A rare cause of gastrointestinal bleeding and intussusception in a patient with undifferentiated pleomorphic sarcoma.

Polish archives of internal medicine
2025

Budd-Chiari syndrome from pleomorphic sarcoma compressing the inferior vena cava: A case report.

Radiology case reports
2025

Case Report: Malignant transformation of maxillary giant cell tumor of bone from EURACAN reference center.

Frontiers in oncology
2025

A case of cardiac undifferentiated pleomorphic sarcoma treated with post-operative radiotherapy followed by heart transplantation.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology
2025

Undifferentiated Pleomorphic Sarcoma of Laryngeal Ventricle: A Case Report.

Oman medical journal
2025

Oral Undifferentiated Pleomorphic Sarcoma: A Novel SPECC1L::TERT Gene Fusion and a Comprehensive Literature Review.

Genes
2025

Transoral Videolaryngoscopic Surgery for an Undifferentiated Pleomorphic Sarcoma of the Tongue Base: A Case Report.

Reports (MDPI)
2025

A Review of Intracardiac Mass Cases Encountered Over a Two-Year Period.

Cureus
2025

Undifferentiated Pleomorphic Sarcoma: A Diagnosis of Exclusion.

Cureus
2025

Optimal Factors That Influence the Establishment of Successful Primary Human Soft-Tissue Sarcoma Cell Lines.

Clinical cancer research : an official journal of the American Association for Cancer Research
2025

Primary leiomyosarcoma of bone: a clinicopathologic and immunohistochemical study of 142 cases.

Pathologica
2025

A rare presentation of a cutaneous metastasis from an undifferentiated pleomorphic sarcoma.

Journal of cancer research and therapeutics
2025

Divergent therapeutic and prognostic impacts of immunogenic features in undifferentiated pleomorphic sarcoma and myxofibrosarcoma.

Cancer immunology, immunotherapy : CII
2025

Perioperative Systemic Therapy in Rare, Chemosensitive Subtypes of Retroperitoneal Sarcoma: A Hospital-Based Propensity Score-Matched Analysis.

Cancers
2025

Hyalinization-based pathologic response and immune infiltration following neoadjuvant radiotherapy with or without immune-checkpoint blockade in localized undifferentiated pleomorphic sarcoma.

ESMO open
2025

Synergistic Effects of ATR Inhibition and Lurbinectedin in Soft-Tissue Sarcomas: The Predictive Role of SLFN11 Expression.

Clinical cancer research : an official journal of the American Association for Cancer Research
2026

Evaluation of PRDM10 gene rearrangement by immunohistochemistry and molecular methods in unclassifiable undifferentiated soft tissue tumors.

Medical molecular morphology
2025

Isolated Limb Perfusion Can Avert Amputation Indication in Initially Nonsalvageable Sarcomas of the Extremities.

Clinical orthopaedics and related research
2025

Oral Soft Tissue and Jawbone Sarcomas: A Retrospective Clinicopathologic Analysis of 128 Cases from Two Institutions and Comprehensive Literature Review.

Head and neck pathology
2025

Molecular Characterization of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma.

Cancers
2025

The role of whole-genome sequencing for guiding systemic therapy in patients with soft tissue sarcoma.

ESMO open
2024

[Gastric Undifferentiated Pleomorphic Sarcoma Presenting as a Rapidly Growing Subepithelial Tumor].

The Korean journal of helicobacter and upper gastrointestinal research
2025

Prognostic factors and the impact of neoadjuvant chemotherapy on the development of metastasis in patients with undifferentiated pleomorphic sarcoma of soft tissue.

International journal of clinical oncology
2025

Severe immunotherapy-related thrombocytopenia in metastatic bone cancer: a multicenter retrospective case series highlighting early recognition and management.

Frontiers in oncology
2025

Real-world data on immune checkpoint inhibitors in advanced sarcomas across multiple European institutions.

Acta oncologica (Stockholm, Sweden)
2025

Incidence, risk factors, and prognostic impact of regional lymph node metastasis in bone sarcoma: a population-based cohort study.

Japanese journal of clinical oncology
2025

Undifferentiated pleomorphic sarcoma invading thoracic aorta treated by thoracic endovascular aortic repair: a case report.

Journal of medical case reports
2025

Undifferentiated Pleomorphic Sarcoma With Mismatch Repair Deficiency Arising From the Heart.

JACC. Case reports
2025

Efficacy of toripalimab in combination with anlotinib in recurrent undifferentiated pleomorphic sarcoma of the sinonasal region: a case report with biomarker analysis.

Frontiers in immunology
2025

Genomics-led approach to drug testing in models of undifferentiated pleomorphic sarcoma.

Molecular oncology
2025

Transdifferentiation of Hairy Cell Leukemia to Lytic and Mass-Producing Histiocytic Sarcoma: A Novel Head and Neck Example and Review of the Literature.

Head and neck pathology
2025

Does Size Outweigh Number in Predicting Survival After Pulmonary Metastasectomy for Soft Tissue Sarcoma? Insights from a Retrospective Multicenter Study.

Annals of surgical oncology
2025

Current and emerging systemic treatment options for malignant fibrous histiocytoma/undifferentiated pleomorphic sarcoma.

International journal of clinical oncology
2025

Rare Case of Grade 3 Undifferentiated Pleomorphic Sarcoma in Left Atrium, Mitral Valve, and Papillary Muscle.

Journal of clinical medicine
2025

Two Simultaneous Primary Cancers: A Case Report.

Cureus
2025

Undifferentiated Pleomorphic Sarcoma of the Prostate, a Rare Cause of Genitourinary Tumour in Men.

Archivos espanoles de urologia
2025

Building a pre-surgical multiparametric-MRI-based morphologic, qualitative, semiquantitative, first and high-order radiomic predictive treatment response model for undifferentiated pleomorphic sarcoma to replace RECIST.

Cancer imaging : the official publication of the International Cancer Imaging Society
2025

Diagnosis and Management of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma in a Large Institutional Cohort.

Journal of cutaneous medicine and surgery
2026

Statistics of Primary Malignant Spine Tumors in Japan: A Retrospective Study Using the Bone and Soft Tissue Tumor Registry in Japan.

Spine
2025

The outcomes and treatment strategies in metastatic soft tissue sarcoma treated with immunotherapy-based therapy: a three-center study.

Frontiers in immunology
2025

Undifferentiated Pleomorphic Sarcoma in Children and Young Adults: A Comprehensive Clinicopathologic, Genomic, and Epigenetic Comparison With Adult Counterparts.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
2025

Recurrence Screening of Undifferentiated Pleomorphic Sarcoma with Giant Cells of the Breast.

Clinical laboratory
2025

A Rare Intruder of the Liver: A Case of Undifferentiated Pleomorphic Sarcoma.

Cureus
2025

Radiation-induced sarcoma after radiotherapy for breast cancer: A retrospective case series.

JPRAS open
2024

DNA Mismatch Repair Deficiency as a Biomarker in Sarcoma.

Surgical oncology insight
2025

Methylation Analysis Reveals Epigenetic Congruence Between Bone Sarcomas With H3-3A Mutations and Malignant Giant Cell Tumors of Bone.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
2025

CRE25-037: Paraneoplastic Syndrome in Undifferentiated Pleomorphic Sarcoma Demonstrates Acquired Antithrombin III Deficiency as Risk Factor for Cancer-Related Morbidity.

Journal of the National Comprehensive Cancer Network : JNCCN
2025

Expression of Cancer-Testis Antigens MAGE-A1, MAGE-A4, NY-ESO-1 and PRAME in Bone and Soft Tissue Sarcomas: The Experience From a Single Center in China.

Cancer medicine
2025

Blue Light Emitting Diode Suppresses Sarcoma Cell Proliferation via the Endogenous Apoptotic Pathway Without Damaging Normal Cells.

Cancer medicine
2025

[The expert consensus on the diagnosis and treatment of skull base and head-neck sarcomas (2024 edition)].

Zhonghua zhong liu za zhi [Chinese journal of oncology]
2025

LDH and hemoglobin outperform systemic inflammatory indices as prognostic factors in patients with soft tissue sarcoma undergoing neoadjuvant treatment.

BMC cancer
2025

Complete Resection of Mediastinal Undifferentiated Pleomorphic Sarcoma.

Annals of thoracic surgery short reports
2025

Paradoxical Response to Neoadjuvant Therapy in Undifferentiated Pleomorphic Sarcoma: Increased Tumor Size on MRI Associated with Favorable Pathology.

Cancers
2025

Radiation-Induced Undifferentiated Pleomorphic Sarcoma in Thyroid: A Rare Occurrence.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India
2025

Subcutaneous undifferentiated pleomorphic sarcoma is more aggressive than pleomorphic dermal sarcoma: Prognosis from a Danish nationwide registry-based cohort.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
2025

Redefining radiologic responses in high-risk soft-tissue sarcomas treated with neoadjuvant chemotherapy: final results of ISG-STS 1001, a randomized clinical trial.

ESMO open
2025

Impact of Tertiary Lymphoid Structure on Prognosis and Tumor Microenvironment in Undifferentiated Pleomorphic Sarcoma.

Cancer science
2025

Laparoscopic Abdominoperineal Resection of Undifferentiated Spindle Cell Sarcomas of the Rectum with Lymph Node Metastases: A Rare Case Report.

Surgical case reports
2024

Malignant fibrous histiocytoma of the mandible: A rare case report with diagnostic challenge and treatment approach.

Journal of oral and maxillofacial pathology : JOMFP
2025

Glucose Transporter 1 (GLUT1) Positivity in Ganglion Cysts: A Diagnostic Caveat Due to Overlap With Perineuriomas and Other Fibromyxoid Lesions.

Cureus
2025

Anlotinib versus Placebo as Adjuvant Therapy for Localized High-Grade Soft-Tissue Sarcomas: A Phase II, Double-Blinded, Randomized Controlled Trial.

Clinical cancer research : an official journal of the American Association for Cancer Research
2025

Clinicopathological background of local recurrence in high grade sarcoma of the extremity with preoperative chemotherapy: a supplementary analysis of JCOG0304.

Japanese journal of clinical oncology
2025

Spontaneous Undifferentiated Pleomorphic Sarcoma With Mast Cell Infiltration in a Sprague-Dawley Rat: A Case Report.

Veterinary medicine and science
2025

Neglected Giant Scalp Tumors: A Report of Two Cases With an Analysis of Delay Factors.

Cureus
2025

Large retroperitoneal mass: A case of an undifferentiated pleomorphic sarcoma.

Radiology case reports
2025

Histological Type-Specific Behavior in Sarcomas: Analysis of Head and Neck Cancer Registry of Japan.

The Laryngoscope
2025

Novel Use and Value of Contrast-Enhanced Susceptibility-Weighted Imaging Morphologic and Radiomic Features in Predicting Extremity Soft Tissue Undifferentiated Pleomorphic Sarcoma Treatment Response.

JCO clinical cancer informatics
2025

Undifferentiated pleomorphic sarcoma in the maxillary sinus: a case report.

Journal of medical case reports
2024

Undifferentiated Pleomorphic Cardiac Sarcoma: A Rare and Often Fatal Diagnosis.

JACC. Case reports
2025

Evolutionary Pressures Shape Undifferentiated Pleomorphic Sarcoma Development and Radiotherapy Response.

Cancer research
2024

Novel Therapeutics in Soft Tissue Sarcoma.

Cancers
2024

Treatment of a Radiation-Associated Femur Fracture with an Intercalary Endoprosthesis: A Case Report.

JBJS case connector
2025

Assessing the Utility of DNA Methylation Profiling in the Classification of Myogenic Sarcomas of Bone.

International journal of surgical pathology
2025

Sarcomas developed in patients with Lynch Syndrome are enriched in pleomorphic soft-tissue sarcomas and are sensitive to immunotherapy.

European journal of cancer (Oxford, England : 1990)
2024

Monitoring Response Using Circulating Tumor DNA in Undifferentiated Pleomorphic Sarcoma: A Case Report.

Cureus
2025

Durvalumab and tremelimumab in patients with advanced rare cancer: a multi-centre, non-blinded, open-label phase II basket trial.

EClinicalMedicine
2024

Among the Masses: Multiple Left Atrial Undifferentiated Pleomorphic Sarcomas.

Ochsner journal
2025

Heterogeneity in response to neoadjuvant radiotherapy between soft tissue sarcoma histotypes: associations between radiology and pathology findings.

European radiology
2025

Histologic and Immunologic Factors Associated with Response to Immune Checkpoint Inhibitors in Advanced Sarcoma.

Clinical cancer research : an official journal of the American Association for Cancer Research
2024

Decoding Chemotherapy Resistance of Undifferentiated Pleomorphic Sarcoma at the Single Cell Resolution: A Case Report.

Journal of clinical medicine
2025

Dual inhibition of BET and EP300 has antitumor activity in undifferentiated pleomorphic sarcomas and synergizes with ferroptosis induction.

Translational oncology
2024

Multimodality imaging challenge: differentiating a pleiomorphic sarcoma of the left atrial appendage from a thrombus.

European heart journal. Imaging methods and practice
2024

High-grade undifferentiated pleomorphic sarcoma of the left elbow diagnosed by ultrasound: A case report.

Asian journal of surgery
2024

[Clinical characteristics of undifferentiated pleomorphic sarcoma from the head and neck].

Zhonghua yi xue za zhi
2024

Abscopal effect-induced spontaneous regression of distant metastases in malignant mesenchymal tumor: a case report.

Frontiers in oncology
2024

Undifferentiated Pleomorphic Sarcoma: A Case Report.

Cureus
2024

Two Cases of Intraocular Undifferentiated Pleomorphic Sarcoma.

Ocular oncology and pathology
2024

A unique tripartite collision tumor of the esophagus: a case report and literature review.

Frontiers in oncology
2024

The Association of Leser-Trélat Sign with Cutaneous Undifferentiated Pleomorphic Sarcoma.

Indian journal of dermatology
2025

Sarcoma: Last Year's Practice Changing Papers.

Annals of surgical oncology
2024

[A Case of Retroperitoneal Primary Undifferentiated Pleomorphic Sarcoma with a Rapid Course].

Hinyokika kiyo. Acta urologica Japonica
2024

Undifferentiated pleomorphic sarcoma of the adrenal gland: a case report and literature review.

Frontiers in oncology
2024

Brain Metastases in Sarcomas: A Multicenter Retrospective Cohort Study.

Cancers
2024

Dysregulation of miRNAs in Soft Tissue Sarcomas.

Cells
2024

Undifferentiated Pleomorphic Sarcoma of the Proximal Thigh With Neoplastic Fever and Metachronous Sternal Metastases: A Case Report and Review of the Literature.

Cureus
2024

Descriptive analysis of incidence, demographic characteristics, and survival outcomes of soft-tissue sarcoma of the extremities in Saudi Arabia.

Scientific reports
2024

Neoadjuvant immunotherapy in the evolving landscape of sarcoma treatment.

Journal for immunotherapy of cancer
2025

The survival, mechanisms of failure, and function after total humeral replacement in patients with primary sarcomas.

Journal of shoulder and elbow surgery
2024

Results of an Integrated Phase I/II Prospective Clinical Trial (NEXIS) for Neoadjuvant Anti-PD-L1 (Durvalumab) and Anti-CTLA-4 (Tremelimumab) With Radiation for High-Risk Soft-Tissue Sarcoma of the Trunk and Extremities.

Cureus
2025

Low-Level MDM2 Amplification by FISH: An Institutional Experience With a Diagnostic Dilemma.

International journal of surgical pathology
2024

Single-cell and spatial transcriptomics identify COL6A3 as a prognostic biomarker in undifferentiated pleomorphic sarcoma.

Molecular cancer
2024

Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trial.

Lancet (London, England)
2025

Nivolumab and sunitinib in patients with advanced bone sarcomas: A multicenter, single-arm, phase 2 trial.

Cancer
2024

Malignant sarcomatous transformation of calvarial fibrous dysplasia: illustrative case.

Journal of neurosurgery. Case lessons
2024

Is intercalary frozen autograft augmented with intramedullary cement and bridging plates fixation a durable reconstruction?

Journal of orthopaedic surgery and research
2025

A Rare Case of Primary Hepatic Undifferentiated Pleomorphic Sarcoma: Exploring Cancer-related Gene Mutations.

Internal medicine (Tokyo, Japan)
2024

PTEN pathogenic variants are associated with poor prognosis in patients with advanced soft tissue sarcoma.

BJC reports
2025

CT and MR imaging of a huge retroperitoneal synovial sarcoma: A case report.

Radiology case reports
Ver todos os 445 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Sarcoma pleomórfico indiferenciado.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Sarcoma pleomórfico indiferenciado

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Severe mitral stenosis due to primary cardiac intimal sarcoma: case report.
    European heart journal. Case reports· 2026· PMID 41858703mais citado
  2. A Phase 1 Study of Neoadjuvant Cabozantinib in Combination With Radiation Therapy for Sarcomas of the Extremities.
    American journal of clinical oncology· 2026· PMID 41770651mais citado
  3. Single-Cell RNA Sequencing Reveals the Cellular and Molecular Differences Between Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma.
    Medical sciences (Basel, Switzerland)· 2026· PMID 41718124mais citado
  4. Immunoreactivity for CD34, Desmin, Keratins, KIT, Alpha-Smooth Muscle Actin, S100, and Vimentin in Malignant Mesenchymal Neoplasms in Guinea Pigs: A Series of 62 Cases From a Single Institution.
    Veterinary medicine and science· 2026· PMID 41631521mais citado
  5. A Japanese Multicenter Database Study of Retroperitoneal Sarcoma: Outcomes of Patients Receiving Eribulin Therapy.
    Asia-Pacific journal of clinical oncology· 2026· PMID 41568593mais citado
  6. ATRX loss in sarcomas is associated with dysregulated gene and transposable element expression, loss of DNA methylation, and worse survival.
    ESMO Rare Cancers· 2026· PMID 41994103recente
  7. Mesenchymal Tissue-Driven Gene Programs Identify EMP3 as a Key Biomarker of Aggressiveness in Undifferentiated Sarcomas.
    Int J Mol Sci· 2026· PMID 41977488recente
  8. Targeting eIF4A-dependent translation in genetically complex sarcoma.
    JCI Insight· 2026· PMID 41945393recente
  9. Gene Expression Profile (GEP) Comparison of Atypical Fibroxanthoma (AFX) and Pleomorphic Dermal Sarcoma (PDS).
    Cancers (Basel)· 2026· PMID 41899538recente
  10. Tumor Size Modifies the Survival Benefit of Chemotherapy in Localized Soft Tissue Sarcomas: A Propensity-Matched Cohort Study.
    J Clin Med· 2026· PMID 41899177recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:2023(Orphanet)
  2. MONDO:0002142(MONDO)
  3. GARD:6963(GARD (NIH))
  4. Busca completa no PubMed(PubMed)
  5. Q1887348(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Sarcoma pleomórfico indiferenciado
Compêndio · Raras BR

Sarcoma pleomórfico indiferenciado

ORPHA:2023 · MONDO:0002142
Prevalência
1-9 / 100 000
Herança
Not applicable
CID-10
C49.9 · Neoplasia maligna do tecido conjuntivo e tecidos moles, não especificados
Ensaios
21 ativos
Início
Adolescent, Adult, Childhood, Elderly
Prevalência
0.0 (Europe)
MedGen
UMLS
C0334463
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades